Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Get Free Trial
Send Info
Hot Stocks
Foghorn doses first patient in Phase 1 combination study of FHD-286 » 07:02
08/31/23
08/31
07:02
08/31/23
07:02
FHTX

Foghorn Therapeutics

$7.67 /

+0.04 (+0.52%)

Foghorn Therapeutics…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Over a month ago
Hot Stocks
Foghorn Therapeutics appoints Quintas-Cardama as Chief Medical Officer » 07:44
08/08/23
08/08
07:44
08/08/23
07:44
FHTX

Foghorn Therapeutics

$9.30 /

+0.04 (+0.43%)

Foghorn Therapeutics…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Earnings
Foghorn Therapeutics reports Q2 EPS (70c), consensus (73c) » 07:06
08/04/23
08/04
07:06
08/04/23
07:06
FHTX

Foghorn Therapeutics

$9.24 /

+0.015 (+0.16%)

Reports Q2 revenue…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Recommendations
Foghorn Therapeutics price target lowered to $19 from $21 at Goldman Sachs » 17:46
06/28/23
06/28
17:46
06/28/23
17:46
FHTX

Foghorn Therapeutics

$8.64 /

+0.15 (+1.77%)

Goldman Sachs lowered the…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Recommendations
Foghorn FHD-286 discontinuation a net positive, says H.C. Wainwright » 11:33
06/28/23
06/28
11:33
06/28/23
11:33
FHTX

Foghorn Therapeutics

$8.29 /

-0.2 (-2.36%)

H.C. Wainwright analyst…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Hot Stocks
Foghorn Therapeutics announces data from Phase 1 study of FHD-286 » 07:02
06/28/23
06/28
07:02
06/28/23
07:02
FHTX

Foghorn Therapeutics

$8.37 /

-0.36 (-4.12%)

Foghorn Therapeutics…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Over a quarter ago
Recommendations
Foghorn Therapeutics moving forward after FDA lifts clinical hold, says Wedbush » 13:03
06/05/23
06/05
13:03
06/05/23
13:03
FHTX

Foghorn Therapeutics

$7.24 /

+0.21 (+2.99%)

Wedbush analyst Robert…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Hot Stocks
Foghorn Therapeutics sees cash runway into 2H25 » 07:18
06/05/23
06/05
07:18
06/05/23
07:18
FHTX

Foghorn Therapeutics

$7.03 /

+0.56 (+8.66%)

"With a focus on…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Hot Stocks
Foghorn Therapeutics to commence Phase 1 combination study of FHD-286 in Q3 » 07:18
06/05/23
06/05
07:18
06/05/23
07:18
FHTX

Foghorn Therapeutics

$7.03 /

+0.56 (+8.66%)

Foghorn plans to commence…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Hot Stocks
Foghorn Therapeutics says FDA lifts clinical hold on Phase 1 study of FHD-286 » 07:17
06/05/23
06/05
07:17
06/05/23
07:17
FHTX

Foghorn Therapeutics

$7.03 /

+0.56 (+8.66%)

Foghorn Therapeutics…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.